A global medical device company received repeat 483s and a Warning letter from the FDA. Halloran provided immediate expert regulatory and quality leadership overseeing interactions with the agency, remediation, and correction of 50+ findings.

An academic research organization (ARO) with rapidly increasing service offerings needed to expand their quality system, ensuring it would withstand sponsor and regulatory authority scrutiny.